Glycopyrrolate
Product Images NDC 70860-781

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 70860-781). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Athenex Pharmaceutical Division, Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gly0b 0002 01

This appears to be a chemical formula or composition. It includes the elements Carbon (C), Hydrogen (H), Bromine (Br), Nitrogen (N), and Oxygen (O), and has a molecular weight (MW) of 398.33. Without additional context, it is not possible to determine the specific compound or its purpose.*

FDA Label Image

Gly0b 0002 02

This is a product label for a 0.2 mg per mL Glycopyrrolate Injection, USP, manufactured for Athenex in India and distributed in the United States with NDC number 70860-781-41. It's a single-dose vial with 1 mL containing Benzyl Alcohol and an expiration date. The lot number is provided for forim oriv use.*

FDA Label Image

Gly0b 0002 03

FDA Label Image

Gly0b 0002 04

FDA Label Image

Gly0b 0002 05

This is a description of a medication called Glycopyrrolate, which is an injection administered intravenously, with a concentration of 4mg per 20mL. It was manufactured in India for Athenex, a company based in Schaumburg, IL. The medication comes in a multi-dose vial containing 20 mL and also contains benzyl alcohol. The NDC number for this medication is 70860-781-44. The lot numbers provided are 838 and 805.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.